AMA submission to the MBS Review Taskforce on vascular recommendations

The AMA supports clinician‑led improvements that align item descriptors and fees with contemporary evidence and practice, simplify claiming, and improve patient access and affordability. We caution against blunt restrictions or administrative hurdles that inadvertently displace appropriate low‑risk care, increase out‑of‑pocket costs, or create barriers to timely diagnosis and management — particularly for people in rural and regional communities.